Dr. Tong Xiaolin

What they personally lead.

Training and recognition

Elected Academician of the Chinese Academy of Sciences (中国科学院院士) in 2021 — one of the very few integrative TCM-Western physicians at this rank; principal investigator of multiple national 973 and key R&D programs on herbal interventions for type 2 diabetes; first or senior author on randomized trials published in Diabetes Care, Journal of Clinical Endocrinology and Metabolism, and Phytomedicine evaluating herbal formulas (including jinlida granules and tianqi capsule) as adjuncts to metformin; led the COVID-19 TCM clinical research expert group during the Wuhan response and has continued post-COVID symptom research

What to expect

Dr. Tong is one of the most senior integrative endocrinologists in China and is appropriate for patients with type 2 diabetes, prediabetes, metabolic syndrome, or stubborn central obesity who want a protocol that combines Western diagnostics (HbA1c, lipid panel, OGTT) with TCM-pattern-based herbal management. As an academician his outpatient slots are scarce and primarily used for complex referrals; expect to be triaged to a senior team member for routine follow-up.

Check the public record

Look up publications, citations, and academic profile on independent platforms before reaching out.

Results are automated searches and may include other individuals with similar names.